員.png)
QQ交談
MSN交談
您所在位置：請輸入產(chǎn)品關(guān)鍵字：
郵編：510660
聯(lián)系人：楊永漢
電話：86-020-82574011
傳真：86-020-32206070
手機(jī)：13802525278
留言：發(fā)送留言
個(gè)性化：www.jianlun45.com
網(wǎng)址：www.jianlun.com
商鋪：http://www.hbwxwy.cn/st199246/
廣州創(chuàng)侖-非法食品添加違禁品檢測試劑盒
- 發(fā)布日期：
- 有效日期：
- 所 在 地：
- 產(chǎn) 地：
- 已獲點(diǎn)擊：
- 2024年11月5日
- 2025年5月5日
- 廣東廣州市
- 美國
- 1246次
【產(chǎn)品簡介】
【詳細(xì)說明】
非法食品添加違禁品檢測試劑盒
廣州健侖生物科技有限公司
廣州健侖生物長期供應(yīng)各種違禁品檢測試紙、違禁品檢測卡、違禁品檢測試劑盒、藥篩試紙、藥篩試劑盒、嗎啡檢測試劑盒、巴比妥檢測試劑盒等。
我司同時(shí)有bzo - bar - coc - thc met - - opi - oxy - mdma - cfp - amp - xtc – bat多聯(lián)檢測卡（膠體金法）
如需訂購或者了解請以下或
mob： 楊 ：
主營品牌：美國NovaBios、美國Cortez、國產(chǎn)創(chuàng)侖等等。
主要用途：篩查違禁品濫用殘留、麻醉藥殘留、興奮藥物殘留等等。
檢測范圍：嗎啡、KET、mamp、MDMA、BZO、THC、巴比妥、MTD、BAR、MDMA、AMP、BUP、PCP、TCA、OXY、MET等等。
產(chǎn)品特點(diǎn)：可以根據(jù)需求自主訂制多聯(lián)卡。多聯(lián)卡自由組合，從二聯(lián)到十五聯(lián)都可以訂制。
非法食品添加違禁品檢測試劑盒
The OXYCODONE One Step Oxycodone Test Strip is a lateral flow chromatographic immunoassay for the qualitative detection of oxycodone in human urine at a cut-off concentration of 100 ng/mL.
This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used.
SUMMARY
Oxycodone is a semi-synthetic opioid with a structural similarity to codeine. The drug is manufactured by modifying thebaine, an alkaloid found in the opium poppy. Oxycodone, like all opiate agonists, provides pain relief by acting on opioid receptors in the spinal cord, brain, and possibly directly in the affected tissues. Oxycodone is prescribed for the relief of moderate to high pain under the well-known pharmaceutical trade names of OxyContin®, Tylox®, Percodan® and Percocet®. While Tylox, Percodan and Percocet contain only small doses of oxycodone hydrochloride combined with other analgesics such as acetaminophen or aspirin, OxyContin consists solely of oxycodone hydrochloride in a time-release form.
Oxycodone is known to metabolize by demethylation into oxymorphone and noroxycodone. In a 24-hour urine, 33-61% of a single, 5mg oral dose is excreted with the primary constituents being unchanged drug (13-19%), conjugated drug (7-29%) and conjugated oxymorphone (13-14%)1. The window of detection for oxycodone in urine is expected to be similar to that of other opioids such as morphine.
The OXYCODONE One Step Oxycodone Test Strip yields a positive result when the oxycodone level in urine exceeds 100 ng/mL. At present, the Substance Abuse and Mental Health Services Administration (SAMHSA) does not have a recommended screening cutoff for oxycodone positive specimens.
【儲存條件及有效期】
儲存條件：原包裝應(yīng)儲存于4～30℃避光干燥處，切忌冷凍。
規(guī)格：40T
有效期：24個(gè)月。
試劑盒應(yīng)在鋁箔袋拆封后1小時(shí)內(nèi)盡快使用；建議在周圍溫度高于30℃或高濕度條件下，盡可能做到即開即用。
以下可以自由COMBO多聯(lián)檢測卡：
有可能的使用
多OPI篩選面板是快速色譜免疫分析，用于定性和同時(shí)檢測人尿中各種組合中的一至十四種以下藥物。 這些藥物的設(shè)計(jì)截止?jié)舛群椭苯有Ｕ齽┤缦拢?/span>
4-Acetamidophenol | Estrone-3-sulfate | Oxolinic acid |
Acetophenetidin | Ethyl-p-aminobenzoate | Oxycodone |
N-Acetylprocainamide | Fenfluramine | Oxymetazoline |
Acetylsalicylic acid | Fenoprofen | Papaverine |
Aminopyrine | Furosemide | Penicillin-G |
Amitryptyline | Gentisic acid | Pentazocine |
Amobarbital | Hemoglobin | Pentobarbital |
Amoxicillin | Hydralazine | Perphenazine |
Ampicillin | Hydrochlorothiazide | Phencyclidine |
Ascorbic acid | Hydrocodone | Phenelzine |
Apomorphine | Hydrocortisone | Phenobarbital |
Aspartame | p-Hydroxyamphetamine | l-Phenylephrine |
Atropine | O-Hydroxyhippuric acid | b-Phenylethlamine |
Benzilic acid | p-Hydroxy-methamphetamine | Phenylpropanolamine |
Benzoic acid | Prednisolone | |
Benzoylecgonine | 3-Hydroxytyramine | Prednisone |
Benzphetamine | Ibuprofen | Procaine |
Bilirubin | Imipramine | Promazine |
Brompheniramine | (-) Isoproterenol | Promethazine |
Caffeine | Isoxsuprine | d,l-Propanolol |
Cannabidiol | Ketamine | d-Propoxyphene |
Cannabinol | Ketoprofen | d-Pseudoephedrine |
Chloralhydrate | Labetalol | Quinidine |
Chloramphenicol | Levorphanol | Quinine |
Chlordiazepoxide | Loperamide | Ranitidine |
Chlorothiazide | Maprotiline | Salicylic acid |
(±) Chlorpheniramine | Meperidine | Secobarbital |
Chlorpromazine | Meprobamate | Serotonin (5-Hydroxytyramine) |
Chlorquine | Methadone | |
Cholesterol | d-methamphetamine | Sulfamethazine |
Clomipramine | (l)-methamphetamine | Sulindac |
Clonidine | Methoxyphenamine | Temazepam |
Cocaine hydrochloride | 3,4-Methylenedioxyethyl-amphetamine | Tetracycline |
Codeine | Tetrahydrocortisone, 3 Acetate | |
Cortisone | (+) 3,4-Methylenedioxy-methamphetamine | |
(-) Cotinine | Tetrahydrocortisone 3 (b-D glucuronide) | |
Creatinine | Methylphenidate | |
Deoxycorticosterone | Morphine-3-b-D-glucuronide | Tetrahydrozoline |
Dextromethorphan | Thebaine | |
Diazepam | Nalidixic acid | Thiamine |
Diclofenac | Naloxone | Thioridazine |
Diflunisal | Naltrexone | Tolbutamine |
Digoxin | Naproxen | Triamterene |
Diphenhydramine | Niacinamide | Trifluoperazine |
Doxylamine | Nifedipine | Trimethoprim |
Ecgonine hydrochloride | Norcodein | Trimipramine |
Ecgonine methylester | Norethindrone | d,l-Tryptophan |
(IR,2S)-(-)-Ephedrine | d-Norpropoxyphene | Tyramine |
l-Ephedrine | Noscapine | d,l-Tyrosine |
(-) Y Ephedrine | d,l-Octopamine | Uric acid |
Erythromycin | Oxalic acid | Verapamil |
b-Estradiol | Oxazepam | Zomepirac |
Parameter | Calibrator | Cut-off(ng/mL) |
THC | 11-nor-D9-THC-9-COOH | 50 ng/ml |
COC | Benzoylecgonine | 300 ng/ml |
PCP | Phencyclidine | 25 ng/ml |
OPI | Morphine | 2000 ng/ml |
MET | Methamphetamine | 1000 ng/ml |
MTD | Methadone | 300 ng/ml |
AMP | Amphetamine | 1000 ng/ml |
BAR | Secobarbital | 300 ng/ml |
BZO | Oxazepam | 300 ng/ml |
TCA | Nortriptyline | 1000 ng/ml |
MDMA | 3,4-Methylenediioxy-MET | 500 ng/ml |
BUP | BUP-3-D-Glucuronide | 10 ng/ml |
EDDP | EDDP | 100 ng/ml |
OPI/MOR | Morphine | 300 ng/ml |
KET | Ketamine | 1,000ng/ml |
TML | Cis-Tramadol | 100ng/ml |
OXY | Oxycodone | 100ng/ml |
PPX | Propoxyphene | 300ng/ml |
K2 | JWH-073/JWH-01 | 50 ng/ml |
FYL | * | 200 ng/ml |
COT | Cotinine | 200 ng/ml |
ALC | Alcohol |
|
美國NOVABIOS多聯(lián)檢測杯簡介：
產(chǎn)品名稱 | 規(guī)格 | 檢測違禁品類型 |
違禁品十聯(lián)檢測杯 | 25T/盒 | MET.AMP.MTD.THC.BAR.TCA.COC.BZO.PCP.OPI |
違禁品十三聯(lián)檢測杯 | 25T/盒 | AMP.BAR.BZO.COC.MET.MOR.MTD.PCP.PPX.TCA.THC.XTC.WADU |
違禁品十二聯(lián)檢測杯 | 25T/盒 | BZO.BAR.COC.THC.MET.OPI.OXY.MDMA.PCP.AMP.BUP.MTD |
非法食品添加違禁品檢測試劑盒
美國NOVABIOS單卡產(chǎn)品簡介：
| 產(chǎn)品名稱 | 英文縮寫 | 檢測閥值 |
| 嗎啡檢測試劑盒 | MOP(OPI) | 300ng/ml |
| mamp檢測試劑盒 | MAMP（MET） | 1000ng/ml |
| K檢測試劑盒 | KET | 1000ng/ml |
| Ecstasy檢測試劑盒 | MDMA | 500ng/ml |
| cocaine檢測試劑盒 | COC | 300ng/ml |
| hemp檢測試劑盒 | THC | 50ng/ml |
| Amphetamine檢測試劑盒 | AMP | 1000ng/ml |
| Benzene two nitrogen Zhuo檢測試劑盒 | BZO | 300ng/ml |
| 巴比妥檢測試劑盒 | BAR | 300ng/ml |
| Methadone檢測試劑盒 | MTD | 300ng/ml |
w the test device, urine specimen, and/or controls to reach room temperature (15-30oC) prior to te
【檢驗(yàn)方法】
在進(jìn)行檢測前必須先完整閱讀使用說明書，使用前將本品和尿樣恢復(fù)至室溫（20℃～30℃）。
- 撕開鋁箔袋，取出試劑盒，應(yīng)在1小時(shí)內(nèi)盡快使用。
- 將試劑盒置于干凈平坦的臺面上，用塑料吸管垂直滴加3滴無空氣泡的尿樣（約100µL）于加樣孔（S）中。
- 等待紫紅色條帶的出現(xiàn)，3～5分鐘時(shí)直接觀察結(jié)果，10分鐘后判定無效。
【檢測結(jié)果示意圖】
INTERPRETATION OF RESULTS
（請參考上圖）
【檢驗(yàn)結(jié)果的解釋】
陽性（+）：僅在控制區(qū)（C）出現(xiàn)一條紫紅色條帶，在檢測區(qū)（T）無紫紅色條帶出現(xiàn)。陽性結(jié)果表明尿液中的濃度在閾值（3000ng/mL）以上。
陰性（-）：出現(xiàn)兩條紫紅色條帶。一條位于檢測區(qū)（T），另一條位于控制區(qū)（C）。陰性結(jié)果表明尿液中的因濃度在閾值（3000ng/mL）以下。
無效：控制區(qū)（C）未出現(xiàn)紫紅色條帶。表明操作不當(dāng)或試劑盒已失效。在此情況下，應(yīng)再次仔細(xì)閱讀說明書，并用新的試劑盒重新測試。如果問題仍然存在，應(yīng)立即停止使用此批號產(chǎn)品，并與當(dāng)?shù)毓?yīng)商。
注意：檢測區(qū)（T）紫紅色條帶可呈現(xiàn)顏色深淺的現(xiàn)象。但是，在規(guī)定的觀察時(shí)間內(nèi)，不論該色帶顏色深淺，即使只有非常弱的色帶也應(yīng)判定為陰性結(jié)果。
我司還提供其它進(jìn)口或國產(chǎn)試劑盒：登革熱、瘧疾、流感、A鏈球菌、合胞病毒、腮病毒、乙腦、寨卡、黃熱病、基孔肯雅熱、克錐蟲病、違禁品濫用、肺炎球菌、軍團(tuán)菌、化妝品檢測、食品安全檢測等試劑盒以及日本生研細(xì)菌分型診斷血清、德國SiFin診斷血清、丹麥SSI診斷血清等產(chǎn)品。
廣州健侖生物科技有限公司是集研制開發(fā)、銷售、服務(wù)于一體的*,公司產(chǎn)品涉及臨床快速診斷試劑、食品安全檢測試劑，藥物濫用快速檢測，動(dòng)物疾病防疫檢測試劑，免疫診斷試劑、臨床血液學(xué)和體液學(xué)檢驗(yàn)試劑、微生物檢驗(yàn)試劑、分子生物學(xué)檢驗(yàn)試劑、臨床生化試劑、有機(jī)試劑等眾多領(lǐng)域，同時(shí)核心代理panbio、focus、qiagen、ibl、cortez、fuller、inbios、binaxnow、lumuquick、日本富士、日本生研等多家*診斷產(chǎn)品集團(tuán)公司產(chǎn)品，致力于為商檢單位、疾病預(yù)防控制中心、海關(guān)出入境*、衛(wèi)生防疫單位,緝毒系統(tǒng)，戒毒中心，檢驗(yàn)檢疫單位、生化企業(yè)、科研院所、醫(yī)療機(jī)構(gòu)等機(jī)構(gòu)與行業(yè)提供*、高品質(zhì)的產(chǎn)品服務(wù)。此外，本公司還開展食品、衛(wèi)生、環(huán)境、藥品等多方面的第三方檢測服務(wù)。
更多產(chǎn)品說明可通過下方的進(jìn)行了解
添加掃一掃二維碼：
【公司名稱】 廣州健侖生物科技有限公司
【 市場部 】 楊永漢
【】
【騰訊 】
【公司地址】 廣州市清華科技園健新基地番禺石樓鎮(zhèn)健啟路63號二期2幢101-103室
神經(jīng)纖維瘤病，血管瘤病和脂肪瘤病指腫瘤多發(fā)的狀態(tài)。
畸胎瘤是性腺或胚胎剩件中的*細(xì)胞發(fā)生的腫瘤，常發(fā)生于性腺，一般含有兩個(gè)以上胚層的成分，結(jié)構(gòu)混亂，也有良性和惡性之分。
? 有些腫瘤的形態(tài)類似于某些幼稚組織，稱為母細(xì)胞瘤。其中也有良性和惡性之分，良性者如骨母細(xì)胞瘤，惡性的則有神經(jīng)母細(xì)胞瘤。
流行病學(xué)
癌癥的流行病學(xué)是利用研究癌癥發(fā)生機(jī)率來推測癌癥的可能成因以及相關(guān)的性質(zhì)。
在一些西方國家，例如美國，目前所有死亡人數(shù)的25%是因癌癥死亡。而每年約有0.5%人口診斷出癌癥。癌癥已經(jīng)超過心血管疾病成為死亡的主要原因。許多第三世界國家的癌癥發(fā)病率卻反而較低，可能因?yàn)閭魅静?、缺乏醫(yī)療資源等造成的高死亡率所導(dǎo)致。隨著瘧疾和肺結(jié)核的控制，第三世界國家的癌癥發(fā)生率則可望上升。這個(gè)現(xiàn)象在流行病學(xué)中稱作疾病轉(zhuǎn)型（epidemiologic transition）。
在西方國家，肝上皮細(xì)胞惡性腫瘤是很罕見的，而在中國與其周邊國家則是主要常見的癌癥之一?？赡苁且?yàn)橐倚透窝椎牧餍谢螯S曲毒素的常見所引起。同樣的因?yàn)槲鼰熢诘谌澜鐕胰遮吰毡?，使得肺癌的發(fā)生率在這些國家中也有逐漸升高的趨勢。
女性和男性嬰兒的癌癥發(fā)生率基本上*。
中國大陸
惡性腫瘤死亡在全死因中的地位，在70年代初僅占死亡總數(shù)的12.57%，二十年后隨著總死亡率的下降，惡性腫瘤死亡率的上升，在1990-1992年度，惡性腫瘤死亡比重上升到17.94%。到2000年，城市惡性腫瘤死亡占總死亡的比重從70年代初的16.25%上升到24.38%，是為死因分類構(gòu)成中*死因。農(nóng)村惡性腫瘤死亡比重也由11.53%上升為18.3%，居第二位主要死因。
癌癥病因和病理生理學(xué)
增殖是體內(nèi)所有細(xì)胞都具備的基本生物學(xué)特性，通常細(xì)胞增殖和細(xì)胞凋亡會(huì)達(dá)到平衡，而且受到嚴(yán)謹(jǐn)?shù)卣{(diào)控以保證器官和組織的完整性。但惡變的細(xì)胞呈無限增殖趨勢，并不同程度地失去原來細(xì)胞固有的形態(tài)和功能（分化障礙）。
Neurofibromatosis, hemangiomatosis, and lipoma are conditions in which tumors are predominant.
Teratoma is a tumor of the totipotent cells in the gonadal or embryonic leftovers, often occurring in the gonads, usually containing more than two germ layers, disorganized and benign and malignant.
? Some tumors are morphologically similar to some naïve tissues, called blastomas. There are also benign and malignant points, benign such as osteoblastoma, malignant neuroblastoma.
Epidemiology
The epidemiology of cancer is the study of the probability of cancer to predict the possible causes of cancer and related properties.
In some Western countries, such as the United States, 25% of all current deaths are due to cancer deaths. About 0.5% of the population diagnoses cancer each year. Cancer has overtaken cardiovascular disease as the leading cause of death. In many third world countries, however, the incidence of cancer is rather low, probably due to high mortality rates due to infectious diseases and lack of medical resources. With the control of malaria and tuberculosis, the incidence of cancer in Third World countries is expected to rise. This phenomenon is called epidemiologic transition in epidemiology.
Hepatic epithelial malignancies are rare in Western countries, but one of the major common cancers in China and neighboring countries. It may be due to the prevalence of hepatitis B or the common occurrence of aflatoxins. The same is true because smoking is becoming more prevalent in Third World countries and the incidence of lung cancer is also on the rise in these countries.
The incidence of cancer among women and males is basically the same.
China Mainland
The death of malignancies among all causes of death accounted for only 12.57% of the total deaths in the early 1970s. Twenty years later, as the overall mortality rate dropped, the mortality rate of malignancies rose. In 1990-1992, the death of malignancies The proportion rose to 17.94%. By 2000, the proportion of urban cancer deaths to total deaths rose from 16.25% in the early 1970s to 24.38%, making it the first cause of death in the composition of cause of death. The proportion of deaths from malignant tumors in rural areas rose from 11.53% to 18.3%, ranking the second leading cause of death.
Causes of cancer and pathophysiology
Proliferation is the basic biological characteristic of all cells in the body. Generally, cell proliferation and apoptosis will be balanced, and they are regulated to ensure the integrity of organs and tissues. However, malignant cells showed an unlimited proliferative trend, and to varying degrees, they lost the original cell morphology and function (differentiation disorders).